# Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers

> **NCT02014870** · PHASE1 · COMPLETED · sponsor: **Immune Targeting Systems Ltd** · enrollment: 29 (actual)

## Conditions studied

- Influenza A

## Interventions

- **OTHER:** 1:1000 Live wild-type A/California/H1N1 2009
- **OTHER:** 1:100 Live wild-type A/California/H1N1 2009
- **OTHER:** 1:10 Live wild-type A/California/H1N1 2009

## Key facts

- **NCT ID:** NCT02014870
- **Lead sponsor:** Immune Targeting Systems Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02014870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02014870, "Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02014870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*